Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on July 23, 2009
J Am Soc Nephrol 20: 1687-1692, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2009010065

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2009010065v1
ASN.2009010065v2
20/8/1687    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paragas, N.
Right arrow Articles by Barasch, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paragas, N.
Right arrow Articles by Barasch, J.

BRIEF COMMUNICATION

Urinary NGAL Marks Cystic Disease in HIV-Associated Nephropathy

Neal Paragas*, Thomas L. Nickolas*, Christina Wyatt{dagger}, Catherine S. Forster*, Meghan Sise*, Susan Morgello{dagger}, Bernd Jagla*, Charles Buchen*, Peter Stella*, Simone Sanna-Cherchi*, Maria Luisa Carnevali{ddagger}, Silvia Mattei{ddagger}, Achiropita Bovino{ddagger}, Lucia Argentiero{ddagger}, Andrea Magnano{ddagger}, Prasad Devarajan§, Kai M. Schmidt-Ott||, Landino Allegri{ddagger}, Paul Klotman{dagger}, Vivette D'Agati*, Ali G. Gharavi* and Jonathan Barasch*

*College of Physicians and Surgeons, Columbia University, New York, New York;
{dagger}The Mount Sinai School of Medicine, New York, New York;
{ddagger}University of Parma, Parma, Italy;
§Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; and
||Max Delbruck Center for Molecular Medicine, Berlin, Germany

Correspondence: Dr. Jonathan Barasch, Columbia University, PS 10-501, 630 West 168th Street, New York, New York 10032. Phone: 212-305-1890; Fax: 212-305-3475; E-mail: jmb4{at}columbia.edu

Received for publication January 16, 2009. Accepted for publication April 22, 2009.

Nephrosis and a rapid decline in kidney function characterize HIV-associated nephropathy (HIVAN). Histologically, HIVAN is a collapsing focal segmental glomerulosclerosis with prominent tubular damage. We explored the expression of neutrophil gelatinase-associated lipocalin (NGAL), a marker of tubular injury, to determine whether this protein has the potential to aid in the noninvasive diagnosis of HIVAN. We found that expression of urinary NGAL was much higher in patients with biopsy-proven HIVAN than in HIV-positive and HIV-negative patients with other forms of chronic kidney disease. In the HIV-transgenic mouse model of HIVAN, NGAL mRNA was abundant in dilated, microcystic segments of the nephron. In contrast, urinary NGAL did not correlate with proteinuria in human or in mouse models. These data show that marked upregulation of NGAL accompanies HIVAN and support further study of uNGAL levels in large cohorts to aid in the noninvasive diagnosis of HIVAN and screen for HIVAN-related tubular damage.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
L. A. Szczech
The Development of Urinary Biomarkers for Kidney Disease Is the Search for Our Renal Troponin
J. Am. Soc. Nephrol., August 1, 2009; 20(8): 1656 - 1657.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP